Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
177.17 USD | +0.26% | +1.06% | -10.23% |
12-03 | Zoetis Inc. Presents at Piper Sandler 36th Annual Healthcare Conference, Dec-03-2024 12:13 PM | |
12-02 | Leerink Initiates Zoetis at Outperform With $215 Price Target | MT |
Capitalization | 79.93B 76.23B 70.69B 62.7B 113B 6,777B 126B 878B 325B 2,787B 300B 294B 12,188B | P/E ratio 2024 * |
32.7x | P/E ratio 2025 * | 29x |
---|---|---|---|---|---|
Enterprise value | 84.15B 80.26B 74.42B 66.01B 119B 7,135B 132B 924B 342B 2,934B 316B 309B 12,832B | EV / Sales 2024 * |
9.08x | EV / Sales 2025 * | 8.62x |
Free-Float |
89.78% | Yield 2024 * |
0.96% | Yield 2025 * | 1.06% |
Last Transcript: Zoetis Inc.
1 day | +0.26% | ||
1 week | +1.06% | ||
Current month | +1.10% | ||
1 month | +0.58% | ||
3 months | -6.75% | ||
6 months | -0.77% | ||
Current year | -10.23% |
Director | Title | Age | Since |
---|---|---|---|
Kristin Peck
CEO | Chief Executive Officer | 52 | 31/12/2019 |
Wetteny Joseph
DFI | Director of Finance/CFO | 52 | 31/05/2021 |
Mike McFarland
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/2020 |
Manager | Title | Age | Since |
---|---|---|---|
Frank D'Amelio
CHM | Chairman | 66 | 30/06/2012 |
Gregory Norden
BRD | Director/Board Member | 66 | 31/12/2012 |
Chairman | 71 | 25/06/2013 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.87% | 1 M€ | -.--% | ||
3.35% | 20 M€ | +16.68% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.26% | +1.06% | -6.49% | -23.45% | 79.93B | ||
+0.89% | +2.29% | -1.42% | -55.20% | 6.19B | ||
+1.36% | +2.37% | +40.43% | -8.11% | 4.14B | ||
-0.15% | +3.34% | +9.81% | -26.75% | 2.85B | ||
-0.24% | -0.73% | +62.49% | -38.20% | 1.95B | ||
+1.70% | -3.87% | +19.53% | -10.18% | 1.29B | ||
+2.22% | +3.80% | -35.80% | -36.57% | 1.04B | ||
-0.26% | +2.16% | -16.84% | -40.78% | 998M | ||
-1.42% | -2.30% | -14.98% | -42.06% | 964M | ||
+3.68% | +1.40% | +118.41% | +24.47% | 970M | ||
Average | +0.80% | +0.72% | +17.52% | -25.68% | 10.03B | |
Weighted average by Cap. | +0.37% | +1.11% | -1.38% | -25.01% |
2024 * | 2025 * | |
---|---|---|
Net sales | 9.27B 8.84B 8.2B 7.27B 13.11B 786B 14.56B 102B 37.71B 323B 34.82B 34.05B 1,413B | 9.73B 9.28B 8.6B 7.63B 13.76B 825B 15.28B 107B 39.58B 339B 36.55B 35.74B 1,484B |
Net income | 2.46B 2.35B 2.18B 1.93B 3.48B 209B 3.87B 27.06B 10.02B 85.9B 9.25B 9.05B 376B | 2.72B 2.59B 2.4B 2.13B 3.84B 230B 4.27B 29.85B 11.05B 94.73B 10.21B 9.98B 414B |
Net Debt | 4.22B 4.03B 3.73B 3.31B 5.97B 358B 6.63B 46.38B 17.17B 147B 15.86B 15.51B 644B | 3.94B 3.76B 3.48B 3.09B 5.57B 334B 6.19B 43.26B 16.02B 137B 14.79B 14.47B 600B |
Date | Price | Change | Volume |
---|---|---|---|
11/12/24 | 177.17 $ | +0.26% | 1,782,356 |
10/12/24 | 176.71 $ | -0.81% | 1,678,161 |
09/12/24 | 178.15 $ | +0.96% | 2,387,445 |
06/12/24 | 176.46 $ | +0.97% | 2,551,210 |
05/12/24 | 174.77 $ | -0.31% | 2,441,959 |
Delayed Quote Nyse, December 11, 2024 at 09:00 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZTS Stock
MarketScreener is also available in this country: United States.
Switch edition